Navigation Links
New Report Just Published: World Prostate Cancer Therapeutics Market Report
Date:7/7/2009

ome Systems Collaborate to Develop Prostate Cancer Test Using Semen II-83 Valera and Spepharm Partner to Market Vantas, and Supprelin-LA II-84 SurModics and AbbeyMoor Collaborate to Develop Products to Treat Prostate Diseases II-84 Dendreon Constructs Manufacturing Facility in New Jersey II-84 MediGene Introduces Prostate Cancer Drug in Italian Market II-85 Gen-Probe Introduces Innovative Test for Prostate Cancer in Europe II-85 DRL Introduces Generic Version of Proscar II-85 Ferring Partners with Astellas on Degarelix License for Prostate Cancer Treatment II-85 Protox Acquires PRX321 Cancer Program from US Public Health Service and Neurocrine II-86 Astex Collaborates with CRT and Newcastle University for New Drug Discovery II-86 Miraculins and Duke University Enter into Collaboration II-86 Bayer Receives Rights to Prostate Cancer and Transplantation Drug Test from Abbott II-86 Encorium Group Signs Contract with Global Biopharmaceutical Company II-86 Paladin Signs an Agreement with Watson for Supply and Sale of Trelstar(R) II-87 BioWa Obtains License for Anti-FGF8 Antibody from Kyowa Hakko II-87 OncoGenex and Isis Pharmaceuticals Expand Partnership II-87 Caprion and AstraZeneca Enter into Collaboration II-88 Innovate Oncology and Prostagenics Enter into Capridine-Beta Development Agreement II-88 Protein Design Labs Sublicenses Antibody-Drug Conjugates Development Rights to Genentech II-88 National Cancer Institute Enters into Agreement with Illumina II-89 Sosei Seeks Marketing Rights for Prostate Cancer Drug in Japan II-89 8. Focus on Select Global Players II-90 Abbott Laboratories (USA) II-90 Aeterna Zentaris Inc. II-90 ALZA Corporation (USA) II-90 Amgen Inc. (USA) II-91 AstraZeneca PLC (UK) II-91 Medimmune, LLC (USA) II-92 Bristol-Myers Squibb Company (USA) II-92 Ce
'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/16/2010)... Stock Exchange Symbol: MS , ... , , ... ... EDMONTON , March 16 ... ...
(Date:3/16/2010)... PharmAthene, Inc. (Amex: PIP ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results ... ... , ... ... ...
(Date:3/16/2010)... March 16 The Gynecologic Cancer Foundation (GCF) and the Claudia ... as the first recipient of the $50,000 GCF/Claudia Cohen Prize for Outstanding ... (SGO) 41st Annual Meeting on Women,s Cancer, meeting in San Francisco ... ... ...
(Date:3/16/2010)... (LSE: SHP,NASDAQ; SHPGY), announces that it has received a Paragraph IV Notice ... New Drug Application ("ANDA") for a generic version of Shire,s 1,mg, 2mg, ... ... ... , ...
Breaking Biology Technology:BioMS Medical Announces 2009 Year End Results 2BioMS Medical Announces 2009 Year End Results 3BioMS Medical Announces 2009 Year End Results 4BioMS Medical Announces 2009 Year End Results 5BioMS Medical Announces 2009 Year End Results 6BioMS Medical Announces 2009 Year End Results 7BioMS Medical Announces 2009 Year End Results 8BioMS Medical Announces 2009 Year End Results 9BioMS Medical Announces 2009 Year End Results 10PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010 2PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010 3Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 2Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 3Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 4Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 5Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 2Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 3Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 4
... 16 /PRNewswire-FirstCall/,-- Shire plc ("Shire" or the "Company") ... biopharmaceutical company, announces that further to,yesterday,s announcement regarding ... the Circular and associated documents to its shareholders.,A ... the new Shire holding,company, to be called Shire ...
... contribute unrestricted $200 Million Gift, NEW YORK, April ... it will be renamed the NYU Elaine,A. and Kenneth ... of its,board of trustees and his wife, whose unrestricted ... history., The announcement was made by Robert I. ...
... 16 Gene Network Sciences, Inc.,(GNS) today ... of Chief Scientific,Officer and a newly constituted ... from both the biopharmaceutical industry and leading ... Dr. James Collins, is Professor,of Biomedical Engineering ...
Other Biology Technology:New Shire Holding Company Proposal 2New Shire Holding Company Proposal 3NYU Medical Center Changes Name to Honor Chairman of Board & Wife 2NYU Medical Center Changes Name to Honor Chairman of Board & Wife 3NYU Medical Center Changes Name to Honor Chairman of Board & Wife 4NYU Medical Center Changes Name to Honor Chairman of Board & Wife 5Gene Network Sciences Names New CSO and Announces New Scientific Advisory Board 2Gene Network Sciences Names New CSO and Announces New Scientific Advisory Board 3
(Date:3/18/2010)... can live for twenty years, fertilizing millions of eggs ... activity. , Danish researchers who have studied ants ... 1992 discovered that in both ant and bee species ... fluid favors the survival of its own sperm over ... stored, leafcutter ant queens neutralize male-male sperm competition with ...
(Date:3/18/2010)... available in Spanish . , Feeding ... as part of their regular diet makes them ... a study by Agricultural Research Service (ARS) scientists ... and overall behavioral activity among young female pigs ... acquired through diet, is the precursor for the ...
(Date:3/18/2010)... Biotech, Inc., ( www.genwaybio.com ) the US-based diagnostic company ... is expanding this cancer testing program internationally. An ... YouTM Cancer Assessment in Greece starting in April. ... as well. GenWay currently offers this test in ... Sergey Sikora, Vice President of Business Development, said, "The ...
Breaking Biology News(10 mins):Females shut down male-male sperm competition in leafcutter ants 2Tryptophan-enriched diet reduces pig aggression 2Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 61905 1Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 61905 2Barbara Fentress Designer of the Denver International Airport and Convention Center Offers Her Private Mansion at Absolute Auction 61902 1Barbara Fentress Designer of the Denver International Airport and Convention Center Offers Her Private Mansion at Absolute Auction 61902 2Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 1Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 2Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 3
... lower cost biometric products and expanded markets, ... Board: BMRX), and Oki Semiconductor Company, a division ... Oki Electric Industry Co, Ltd.,jointly announced that they ... result in significantly lowering bioMETRX,s overall build costs ...
... at MIT have come up with a mathematical approach for ... species to identify occurrences of natural selection in an organisms ... of a gene, that is, the pattern of fast or ... and uses that signature to infer gene function or to ...
... bird in hand is worth two in the bush may ... the lab of ASU School of Life Sciences Professor Roy ... at the Biodesign Institute. , There, associate research scientist ... targets to develop a vaccine against a leading poultry disease, ...
Other Biology News:bioMETRX Incorporates OKI's Fingerprint Engine in its smartTOUCH Product Line 2bioMETRX Incorporates OKI's Fingerprint Engine in its smartTOUCH Product Line 3Gene's 'selective signature' aids detection of natural selection in microbial evolution 2Gene's 'selective signature' aids detection of natural selection in microbial evolution 3Solving an avian scourge could also provide benefits to human health 2Solving an avian scourge could also provide benefits to human health 3
Rabbit polyclonal to QKI...
... PCR Optimization Kits without ammonium sulfate are ... PCR, such as Taq and AmpliThem™™ DNA ... of PCR systems in one experiment by ... primers into the PreMixes supplied with the ...
... MasterAmp™ PCR Optimization Kits with ammonium ... used in PCR, such as Tfl, Tth, ... improve the performance of PCR systems in ... template, and PCR primers into the PreMixes ...
... Application: A cleaning agent for ... surfaces, countertops, and pipettors. ... eliminating RNase contamination from microcentrifuge ... reactions. ,RNase Zap (R) ...
Biology Products: